137 related articles for article (PubMed ID: 37950887)
1. Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
Minter DJ; Appa A; Chambers HF; Doernberg SB
Clin Infect Dis; 2023 Nov; 77(11):e57-e68. PubMed ID: 37950887
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence.
van der Vaart TW; Prins JM; Goorhuis A; Lemkes BA; Sigaloff KCE; Spoorenberg V; Stijnis C; Bonten MJM; van der Meer JTM
Clin Infect Dis; 2024 Apr; 78(4):846-854. PubMed ID: 38157401
[TBL] [Abstract][Full Text] [Related]
3. [Methicillin-susceptible Staphylococcus aureus bacteraemia].
Gueissaz L; Hauri N; Kocher J; Lavallée MA; Munday MF; Renggli L; Béguelin C
Rev Med Suisse; 2022 Oct; 18(799):1889-1895. PubMed ID: 36226450
[TBL] [Abstract][Full Text] [Related]
4. Clinical Management of
McMullan BJ; Campbell AJ; Blyth CC; McNeil JC; Montgomery CP; Tong SYC; Bowen AC
Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32759380
[No Abstract] [Full Text] [Related]
5. Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice.
Minter DJ; Appa A; Chambers HF; Doernberg SB
Clin Infect Dis; 2023 Nov; 77(11):1489-1491. PubMed ID: 38031168
[No Abstract] [Full Text] [Related]
6. Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.
Westgeest AC; Buis DTP; Sigaloff KCE; Ruffin F; Visser LG; Yu Y; Schippers EF; Lambregts MMC; Tong SYC; de Boer MGJ; Fowler VG
Clin Infect Dis; 2023 Oct; 77(8):1092-1101. PubMed ID: 37310693
[TBL] [Abstract][Full Text] [Related]
7. Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia.
Liu C; Strnad L; Beekmann SE; Polgreen PM; Chambers HF
Clin Infect Dis; 2019 Jul; 69(3):530-533. PubMed ID: 30601989
[TBL] [Abstract][Full Text] [Related]
8. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
Martin L; Harris MT; Brooks A; Main C; Mertz D
BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
[TBL] [Abstract][Full Text] [Related]
10. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469556
[TBL] [Abstract][Full Text] [Related]
12. Update on Staphylococcus aureus bacteraemia.
Tabah A; Laupland KB
Curr Opin Crit Care; 2022 Oct; 28(5):495-504. PubMed ID: 35942696
[TBL] [Abstract][Full Text] [Related]
13. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline for the treatment of methicillin-resistant
White BP; Barber KE; Stover KR
Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
[TBL] [Abstract][Full Text] [Related]
15. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus bacteremia and pneumonia.
Ganesan A
Dis Mon; 2008 Dec; 54(12):787-92. PubMed ID: 18996281
[No Abstract] [Full Text] [Related]
17. Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing.
Park KH; Greenwood-Quaintance KE; Uhl JR; Cunningham SA; Chia N; Jeraldo PR; Sampathkumar P; Nelson H; Patel R
PLoS One; 2017; 12(6):e0179003. PubMed ID: 28575112
[TBL] [Abstract][Full Text] [Related]
18. [Staphylococcus aureus Bacteraemia - an Interdisciplinary Challenge].
Hagel S; Kaasch AJ; Weis S; Seifert H; Pletz MW; Rieg S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Mar; 54(3):206-216. PubMed ID: 30866024
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
20. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
